Drug repositioning targeting glutaminase reveals drug candidates for the treatment of Alzheimer's disease patients.
Abdulahad BayraktarXiangyu LiWoonghee KimCheng ZhangHasan TurkezSaeed ShoaieAdil MardingluPublished in: Journal of translational medicine (2023)
This study method effectively identified an Alzheimer's disease marker and compounds targeting the marker and interconnected biological processes by use of multiple computational approaches. Our results highlight the importance of synaptic glutamate signalling in Alzheimer's disease progression. We suggest repurposable drugs (like parbendazole) with well-evidenced activities that we linked to glutamate synthesis hereby and novel molecules (SA-25547) with estimated mechanisms for the treatment of Alzheimer's patients.